Wegovy Gets F.D.A. Approval for MASH

Wegovy has been approved for use among the growing number of Americans who have MASH.

News
Are Samosas Unhealthy? Some Indians Find Official Advice Hard to Swallow.

A government advisory noting the high fat and sugar levels in many popular snacks was seen by some as an attack on India’s beloved street food.

News
Pill Causes Major Weight Loss in Eli Lilly Trial’s Results

The company said it planned to seek Food and Drug Administration approval for the drug, orforglipron, before the end of the year.

News
Avoiding Ultraprocessed Foods Might Double Weight Loss

In a new trial, people consumed more calories and had more cravings when they ate ultraprocessed foods.

News
Obesity Prediction Could Be Guided by Genetic Risk Scores

Researchers hope that a better understanding of which genes contribute to excess weight could help with prevention starting in childhood.

News
Study Suggests Weight-Loss Pill is as Effective as Ozempic

The drugs in development include a pill that a new trial suggests is about as effective as Ozempic.

News
Is There Really a Chronic Disease Epidemic? It’s Complicated.

Robert F. Kennedy Jr. wants to return the nation to a time when he believes Americans were healthier. Not so fast, many researchers say.

News
Why Patients Are Being Forced to Switch to a 2nd-Choice Obesity Drug

CVS Caremark decided to stop offering Zepbound in favor of Wegovy for weight loss. It’s the latest example of limits imposed by insurance that disrupt treatments for patients.

News
What to Know About Eli Lilly’s Daily Pill for Weight Loss

Eli Lilly reported promising results from a study of its experimental oral drug that could rival popular injections to treat obesity and diabetes.

News
Patients Cut Off From Cheaper Obesity Drugs as FDA Halts Sales of Copycats

U.S. regulators are trying to shut down the industry for compounded weight-loss drugs, which could result in higher costs or suspend treatment for patients.

News